Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 8-K Event Other events
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Open-market sale SVP, Finance & Accounting sold 4,949 shares at $7.87 ($38,958)
  9. 4 Open-market sale Chief Medical Officer sold 4,963 shares at $7.87 ($39,068)
  10. 4 Open-market sale Chief Legal Officer sold 7,281 shares at $7.87 ($57,315)
  11. 4 Open-market sale Chief Operating Officer sold 1,817 shares at $7.87 ($14,303)
  12. 4 Open-market sale Chief Scientific Officer sold 2,166 shares at $7.87 ($17,051)
  13. 4 Open-market sale Chief Commercial Officer sold 1,583 shares at $7.87 ($12,461)
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 8-K Event Material agreement · New debt or obligation

Page 9 of 41 · 809 filings